SANCHEZ-IBARRA, Héctor E. et al. Complete Screening of Exons 2, 3, and 4 of KRAS and NRAS Genes Reveals a Higher Number of Clinically Relevant Mutations than Food and Drug Administration Quantitative Polymerase Chain Reaction-Based Commercial Kits. Rev. invest. clín. [online]. 2020, vol.72, n.6, pp.337-343.  Epub Apr 09, 2021. ISSN 2564-8896.